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Abstract
Background: Because of previously reported ethnic differences in determinants and markers of
obesity and related metabolic disorders, we sought to investigate circulating levels of adiponectin
and their correlates in a sub-Saharan African (sSA) population.
Subjects and Methods: We studied 70 non-diabetic volunteers (33M/37F) living in Yaoundé,
Cameroon, aged 24–69 yr, with BMI 20–42 kg/m2. In all participants we measured waist
circumference and total body fat by bioimpedance, and obtained a fasting venous blood sample for
measurement of plasma glucose, serum insulin and adiponectin concentrations. We performed a
euglycaemic hyperinsulinaemic clamp in 1/4 subjects, and HOMAIR was used as surrogate of fasting
insulin sensitivity index since it best correlates to clamp measurements.
Results: Males had lower adiponectin levels than females (8.8 ± 4.3 vs. 11.8 ± 5.5 μg/L). There was
no significant correlation between adiponectin and total body fat (rs = -0.03; NS), whereas
adiponectin was inversely correlated with waist circumference (rs = -0.39; p = 0.001). Adiponectin
correlated negatively with insulin resistance (rs = -0.35; p = 0.01). In a regression analysis using
fasting adiponectin concentration as the dependent variable, and age, HOMAIR, waist
circumference, and fat mass as predictors, waist circumference (β = -3.30; p = 0.002), fat mass (β
= -2.68; p = 0.01), and insulin resistance (β = -2.38; p = 0.02) but not age (β = 1.11; p = 0.27) were
independent predictors of adiponectin. When considering gender, these relations persisted with
the exception of waist circumference in females.
Conclusion: Adiponectin correlates in this study population are comparable to those observed in
Caucasians with the exception of waist circumference in women. The metabolic significance of
waist circumference is therefore questioned in sSA women.
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Adiponectin, an adipose-specific protein, has gained
much attention due to its effect on glucose homeostasis
and regulation of energy metabolism, making it a candi-
date link between obesity and insulin resistance [1], and a
potential therapeutic pathway. Studies in Caucasians indi-
cate that circulating adiponectin levels are lower in
patients with type 2 diabetes, obesity, and cardiovascular
disease than in background populations [2]. Circulating
adiponectin levels correlate inversely with body mass sta-
tus and positively with insulin sensitivity, measured either
by the hyperinsulinaemic euglycaemic clamp technique
or other surrogate methods [3-6]. However, there are indi-
cations from metabolic in vivo and in vitro studies that
ethnic differences exists in the way adipose tissue and its
distribution influences whole body metabolism. For
example there are reports of lower antilipolytic effect of
insulin in women of African descent compared to Cauca-
sians [7,8]. Moreover, the relation between insulin sensi-
tivity and the topographic distribution of adiposity is
subject to ethnic-specific variations [9], but circulating
levels and correlates of adiponectin in sub-Saharan Afri-
cans have not been investigated. In the present study, we
examined, in healthy non-diabetic volunteers, the associ-
ations between circulating serum adiponectin concentra-
tions and insulin sensitivity measured by a surrogate
insulin sensitivity index, validated against the hyperin-
sulinaemic euglycaemic clamp technique.
Methods
We studied 70 non diabetic Cameroonians (33 males and
37 females) aged 42 ± 10.6 years. All participants had a
stable weight (< 5% variation) over 3 months prior to the
study. Individuals were excluded from the study if they
had physician – diagnosed diabetes, fasting blood glucose
concentration > 1.25 g/L, any ongoing disease except well-
controlled hypertension, or if they were currently receiv-
ing medications known to affect glucose and/or lipid
metabolism. We performed all measurements at the
National Obesity Centre, Yaoundé, starting between 8
and 10 AM after a 10 to 12-hour overnight fast. Partici-
pants were advised to avoid intense physical activity the
day prior to, and on the day of the investigation and to
have their last meal comprising 50–55% carbohydrates
not later than 8 PM the day preceding investigations.
Anthropometric measurements
Weight was measured to the nearest 0.1 kg (SECA, Ger-
many). Height was measured to the nearest 0.5 cm using
a wall – mounted stadiometer. BMI was calculated as
weight (in kg) divided by the square of the height (in
metres). Waist circumference was measured to nearest 1
cm at the level of the umbilicus (L4 - L5) and at the end of
expiration with the subject upright and his/her hands by
the side. Percentage body fat and total fat mass were meas-
ured by bioelectric impedance analysis (OMRON BF 302,
OMRON Matsusaka Co., Ltd. Japan). For each parameter,
2 measurements were taken and the average used in the
analysis.
Metabolic investigations
In all the subjects we collected two fasting venous blood
samples from an antecubital vein for the determination of
circulating glucose, insulin and adiponectin levels. In a
representative sub sample of 16 subjects, we performed a
120-min euglycaemic hyperinsulinaemic clamp at 80
mU/min/m2 insulin infusion rate in order to measure
whole body insulin sensitivity. Fasting insulin sensitivity
indices were derived from fasting insulin and glucose
measurements and were compared to the clamp measure-
ments and yielded the following correlation coefficients:
Fasting insulin (r = -0.70; p = 0.008), HOMAIR (r = -0.76;
p = 0.004) and QUICKI (r = 0.67; p = 0.01) Glucose/Insu-
lin (r = 0.50; p = 0.06). HOMA had the highest correlation
coefficient with clamp-measured whole body insulin sen-
sitivity and was therefore used as surrogate of insulin sen-
sitivity in the study population.
Biochemical measurements
Plasma glucose concentration was determined using the
glucose oxidase method. Adiponectin and insulin levels
(intra-assay CV = 1.78–6.21%) were determined by RIA
(Linco Research Inc, St Charles, MO, USA) at the St-Louis
University Hospital, Department of Hormonal Biology,
Paris. Adiponectin and insulin were measured on serum
samples that had been stored at -80°C for 2–4 months
and shipped in thermo boxes on dry ice. All assays were
run in duplicate.
Statistical analyses
Statistical analyses were performed using the Statistical
Package for Social Sciences, SPSS® for Windows, Version
12. Results are expressed as frequencies or mean ± SD
unless otherwise stated. Comparison across groups was
done using one-way analysis of variance (ANOVA) with
further group-to-group comparison using the non-para-
metric Mann-Whitney U test. Correlations between varia-
bles was analysed using the non-parametric Spearman
Rank Order Test. Linear regression analysis was used to
determine independent predictors of serum adiponectin
levels.
Ethical considerations
The study protocol was approved by the Review Commit-
tee of the Faculty of Medicine and Biomedical Sciences,
University of Yaoundé 1, Cameroon. The study was con-
ducted according to the principles expressed in the Decla-
ration of Helsinki, and written informed consent was
obtained from all participants.Page 2 of 5
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Characteristics of the study population
The study population comprised 33 males aged 41.7 ±
10.5 years, and 37 women aged 42.2 ± 10.9 years (NS). Of
the 70 subjects, 16 (9M, 7F) had a BMI < 25 kg/m2 (nor-
mal weight), 28 (17M, 11 F) had a BMI between 25 and
29.9 kg/m2 (overweight) and 26 (7M, 19F) had a BMI ≥
30 kg/m2 (obese). Women had significantly higher total
body fat compared to men (31.8 ± 9.2 vs. 20.7 ± 8.7%).
Mean waist girth in cm was 93.0 ± 12.4 in women and
91.9 ± 11.1 in men (NS). Insulin sensitivity was also com-
parable in women and men (HOMA = 0.99 ± 0.51 vs. 1.02
± 0.51, NS). Table 1 shows the characteristics of the study
population by gender and BMI class.
Correlates of circulating adiponectin levels
Women had higher circulating adiponectin levels com-
pared to men (11.4 ± 4.8 vs. 8.8 ± 4.3 mg/L, p = 0.02). As
shown in table 1, adiponectin levels were higher in over-
weight and obese women compared to men, but not in
the normal weight sub group in which the levels were
comparable in women and men. Fasting adiponectin lev-
els were highest in the normal weight group, when com-
pared to the overweight and obese groups, but there was
no significant correlation between adiponectin and BMI
(rs = -0.16; p = 0.20) or with total body fat (rs = -0.03; p =
0.81). Adiponectin levels were inversely correlated nega-
tively with waist circumference (rs = -0.39; p = 0.001) and
insulin resistance as measured by the HOMAIR(rs = -0.353;
p = 0.01).
Gender-specific and multivariate analyses
In a regression analysis using fasting adiponectin concen-
tration as the dependent variable, and age, HOMAIR, waist
circumference, and fat mass as predictors, waist circumfer-
ence (β = -3.30; p = 0.002), fat mass (β = -2.68; p = 0.01),
and insulin resistance (β = -2.38; p = 0.02) but not age (β
= 1.11; p = 0.27) were independent predictors of adi-
ponectin. When taking into consideration gender, all the
associations persisted in men. In women, the associations
between adiponectin and total fat, and adiponectin and
waist circumference were not statistically significant. Cor-
relates of adiponectin in women and men are shown in
figure 1.
Discussion
The present study is the first investigation of adiponectin
and its correlates in subjects from sub-Saharan Africa. It
confirms most of the current knowledge on adiponectin
acquired from other populations with the exception of a
less clear relation with adiposity and the surrogates of its
topographic distribution, especially in women. In fact, no
correlation existed between adiponectin levels and waist
circumference in sSA women in the present study.
While the measure of insulin sensitivity has been vali-
dated in the study group against the gold standard meas-
ure which is the euglycaemic hyperinsulinaemic clamp, it
can be questioned whether waist circumference is an
appropriate surrogate of intra abdominal fat. In fact, Love-
joy et al. observed that, at similar levels of BMI and waist-
to-hip ratio, African-American women had smaller vis-
ceral fat compared to Caucasian women [10]. In addition
WHR was correlated with fasting insulin only in Cauca-
sians [10]. Similarly, the group of Albu found a lower vis-
ceral/sub cutaneous tissue in obese black women
compared to whites at comparable levels of WHR [11].
These discrepancies between imaging techniques for the
measurement of visceral adipose tissue and clinical surro-
gates would explain at least partially the need for ethnic-
specific cut points for waist circumference in the defini-
tion of risk and/or metabolic syndrome as attempted by
IDF in 2005 [12].
In addition to this, the present study provides a strong
indirect indication of the questionable metabolic signifi-
cance of waist circumference in the study population. In
fact, contrasting with the unclear relation between waist
circumference and adiponectin levels, waist was associ-
ated with insulin resistance. Population-based epidemio-
logical studies had suggested similar assumptions since
waist circumference was not associated with fasting and 2
h blood glucose in Cameroon but was the most consistent
component of the metabolic syndrome [13]. A growing
Table 1: Characteristics of the study population by sex and obesity class
Normal weight (n = 16) Overweight (n = 28) Obese (n = 26)
M F P M F P M F P
N 9 7 17 11 7 19
Age (years) 37.1 ± 13.9 39.3 ± 7.5 0.72 41.4 ± 9.2 37.8 ± 10.9 0.36 48.1 ± 4.1 45.9 ± 11.0 0.61
BMI (kg.m-2) 22.2 ± 1.2 23.5 ± 1.4 0.07 27.5 ± 1.4 28.2 ± 1.4 0.20 32.2 ± 2.0 35.2 ± 3.1 0.03
Fat mass (kg) 12.2 ± 4.1 19.7 ± 3.8 0.002 20.5 ± 2.9 28.4 ± 2.5 0.000 32.0 ± 8.3 38.4 ± 7.0 0.06
Waist girth (cm) 77.3 ± 5.3 79.6 ± 3.2 0.35 95.4 ± 4.5 88.6 ± 6.1 0.005 103.7 ± 2.9 100.7 ± 11.5 0.51
HOMAIR index 0.68 ± 0.14 0.72 ± 0.34 0.93 0.96 ± 0.51 0.94 ± 0.42 0.91 1.36 ± 0.53 1.13 ± 0.61 0.41
Adiponectin (mg/L) 12.8 ± 3.4 13.0 ± 8.2 0.82 8.1 ± 4.0 11.6 ± 3.3 0.03 5.3 ± 1.7 10.7 ± 4.3 0.003Page 3 of 5
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Correlates of serum adiponectin levels by sexFigure 1
Correlates of serum adiponectin levels by sex. Bivariate correlation between fasting adiponectin levels and fat mass 
(upper panel), waist circumference (mid panel) and insulin resistance (lower panel) in men (left) and women (right). Spearman 
correlation coefficient (r) and significance (p) indicated in the figures.
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hypothesis concerns the effect of the duration of exposure
to obesity that might explain the differences in the rela-
tion with metabolic outcome as would indicate life course
studies [14]. Finally, recently Sniderman et al. developed
the concept of adipose tissue overflow in Asians, hypoth-
esising that superficial subcutaneous adipose tissue com-
partment is larger in whites than in South Asians, with a
risk of earlier exhaustion of the storage capacity of their
superficial subcutaneous adipose tissue compartment
resulting in earlier metabolic complications of upper
body obesity at lower absolute masses of adipose tissue
[15]. We cannot exclude a similar possibility in Africans.
In conclusion, correlates of adiponectin in the sSA popu-
lation studied are similar to observations in Caucasians,
with the exception of the relation with waist circumfer-
ence in women suggesting either the inappropriateness of
waist as clinical surrogate for abdominal fat in this popu-
lation, or a different metabolic meaning of this parameter.
Therefore, further studies aiming at validating better clin-
ical surrogates for abdominal fat are warranted.
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